Answers are grounded in this paper and cite their sources.
BACKGROUND: There are paramount data relating to comparison of clinical outcomes among peritoneal dialysis (PD) patients using icodextrin or low-glucose degradation product (GDP) neutral-pH peritoneal dialysis fluid (PDF) versus conventional glucose-based PDF, generating inconsistent or contradictory results. However, studies comparing between patients treated with icodextrin and those with low-GDP neutral-pH PDF are relatively scare or lacking. METHODS: We reported a retrospective observational study of 130 patients with incident end-stage renal disease on continuous ambulatory peritoneal dialysis. They were divided into three groups: conventional glucose-based (GLU group), icodextrin-based (ICO group), or low-GDP and neutral-pH-based (BAL group) PDFs. We compared patient mortality, technique failure, dropout from PD, and peritonitis rate among them. RESULTS: In the adjusted model of Cox regression analysis, no significant difference in patient mortality and peritonitis risk was observed among GLU, ICO, and BAL groups. The ICO group had a reduced risk of technique failure and dropout from PD compared with the GLU group (P = 0.03; P = 0.003) and also a reduced risk of dropout from PD in comparison with the BAL group (P = 0.03). CONCLUSION: [1] No significant difference in patient mortality and peritonitis risk was observed among GLU, ICO, and BAL groups; [2] the ICO group had a reduced risk of technique failure compared with the GLU group; [3] the ICO group had a reduced risk of dropout from PD compared with both GLU and BAL groups, and [4] no significant difference was identified among the three groups in terms of preservation of residual renal function, measured by Kt/V or creatinine clearance.
No takes yet. Share an insight, caveat, or question.
Ke et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: